Karen Zaderej

Karen Zaderej

Former CEO and PresidentatAxogen· In proxies 2021–2024

Pay in FY2024-55% from the year before · Axogen stock +141.3% the same year

Karen Zaderej was paid $2.5M in FY2024 (Dec), down 55%. Axogen stock rose 141.3% that year.

Pay$100 in the stock at the end of FY20 → $92
Pay is from the Summary Compensation Table of each Axogen proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AxogenPublic company · 5 yr
    • Former CEO and President2021 – Present · 5 yrStock in role +178%
  2. Directors for EyePoint Pharmaceuticals, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?